Henry Schein Inc. Stock
Henry Schein Inc. Stock
A loss of -1.300% shows a downward development for Henry Schein Inc..
Our community is currently high on Henry Schein Inc. with 13 Buy predictions and 3 Sell predictions.
As a result the target price of 78 € shows a slightly positive potential of 1.96% compared to the current price of 76.5 € for Henry Schein Inc..
For the coming years our community has positive and negative things to say abot the Henry Schein Inc. stock. Criterium "Company culture" gathered the most positive votes but regarding "Company culture" there were negative voices in the community.
Pros and Cons of Henry Schein Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
B****
?
W********* I********* f** t** n*** y****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Henry Schein Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Henry Schein Inc. | -1.300% | 2.685% | 0.000% | 35.255% | 17.801% | 10.934% | 18.019% |
| Dexcom Inc. | 0.550% | 1.381% | 13.622% | 11.941% | 28.053% | -33.224% | -33.182% |
| Baxter International | 0.680% | 5.026% | 18.981% | 17.950% | 46.207% | -39.848% | -62.571% |
| Idexx Laboratories Inc. | -0.510% | 4.725% | 1.622% | -9.032% | -13.171% | 9.894% | -12.813% |
Comments
Henry Schein (HSIC) had its "buy" rating reaffirmed by BTIG Research. They now have a $100.00 price target on the stock.
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) had its "buy" rating reaffirmed by Citigroup Inc..
Show more
Ratings data for HSIC provided by MarketBeat
Henry Schein (HSIC) had its price target raised by Piper Sandler from $91.00 to $95.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for HSIC provided by MarketBeat